BioSig Technologies, Inc. STEX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.49M+1.6% | $1.47M-1.3% | $1.49M+169% | $554K+2,538% | $21K-30.0% | ||
| -$3.06M-6,339% | $49K0.0% | $49K0.0% | $49K0.0% | $49K-92.2% | ||
| $2.94M— | —— | —— | —— | —— | ||
| -$46.69M+89.0% | -$424.01M-2,621% | -$15.58M+23.5% | -$20.37M-624% | -$2.81M-156% | ||
| -$0.27+96.7% | -$8.23-1,651% | -$0.47+36.5% | -$0.74-429% | -$0.14-367% | ||
| 174.6M+264% | 48M+43.8% | 33.4M+20.4% | 27.7M+33.3% | 20.8M+48.0% | ||
| 174.6M+264% | 48M+43.8% | 33.4M+20.4% | 27.7M+33.3% | 20.8M+48.0% | ||
| -$497K+71.7% | -$1.75M0.0% | -$1.75M0.0% | -$1.75M0.0% | -$1.75M— | ||
| —— | —— | —— | —— | $199K+95.1% | ||
| —— | $2.01M0.0% | $2.01M0.0% | $2.01M0.0% | $2.01M— | ||
| $25.37M-48.0% | $48.82M+5,698% | $842K-84.3% | $5.37M+159% | $2.07M— | ||
| -$48.61M+88.5% | -$422.41M-2,259% | -$17.91M+4.9% | -$18.83M-570% | -$2.81M-156% | ||
| $2.94M— | —— | —— | —— | —— | ||
| -$11K— | —— | —— | —— | —— | ||
| —— | $0+100% | -$15K+66.7% | -$45K-7.1% | -$42K+2.3% | ||
| $1.93M— | —— | $1.99M— | —— | $70K+312% | ||
| $403K— | —— | —— | —— | —— | ||
| -$1.64M-104% | $36.78M+175% | $13.4M— | $0-100% | $4.7M+469,900% | ||
| -$1.5M+93.9% | -$24.47M— | —— | —— | —— | ||
| -$10.18M-237% | -$3.02M+39.9% | -$5.02M-293% | -$1.28M-14.6% | -$1.12M-135% | ||
| —— | $0-100% | $14K-65.9% | $41K0.0% | $41K0.0% | ||
| $37.18K— | —— | —— | —— | $818K+81,700% | ||
| $25K— | —— | —— | —— | —— | ||
| -$119K— | —— | —— | —— | —— | ||
| -$34.25M+14.7% | -$40.16M-768% | -$4.63M+76.7% | -$19.81M-569% | -$2.96M-157% | ||
| -$35.75M+14.1% | -$41.63M-581% | -$6.11M+70.0% | -$20.37M-582% | -$2.98M-152% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is BioSig Technologies, Inc.'s revenue?
- BioSig Technologies, Inc. (STEX) generated $40.0K in revenue over the trailing twelve months, up 122.2% year over year.
- Is BioSig Technologies, Inc. profitable?
- BioSig Technologies, Inc. is not currently profitable: it reported a net loss of $506.7M over the trailing twelve months, a -25825.0% net margin.
- What are BioSig Technologies, Inc.'s profit margins?
- Gross margin is 80.1% and operating margin is -32155.0%, with a -25825.0% net margin.
- What is BioSig Technologies, Inc.'s earnings per share?
- BioSig Technologies, Inc.'s diluted EPS over the trailing twelve months is $-9.71.
- Where does BioSig Technologies, Inc.'s income statement data come from?
- Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
